Kansas Crimson

Walrus wrote: ↑Mon May 10, 2021 3:07 pm I must say, it's pretty cool holding $80,000 in your hands.

MJ23 wrote: ↑Mon May 10, 2021 3:49 pm Since you felt the need to share it with us, I'll bite. Why did you need to hold $80,000 in your hands?

Walrus wrote: ↑Fri May 07, 2021 11:32 am

CrimsonNBlue wrote: ↑Fri May 07, 2021 11:13 am Vaccine passports is the only path forward.

Good one.

I was talking with someone this week and we both agreed that big pharma and big tech want this kind of segregation. Fortunately, only 40% of Americans have taken it, so the majority will prevail. We were also talking about how it's funny that we teach our children in schools to "question everything", but somehow when we become adults, it's "follow the media." Well, those who cannot think for themselves, they can follow.

PhDhawk wrote: ↑Mon May 10, 2021 9:44 pm Oh, tell me more about how you're concerned that the vaccine is more dangerous than the virus.

Lethal black fungus that rots organs emerges in Covid-19 patients across India

https://www.telegraph.co.uk/global-heal ... ts-across/

PhDhawk wrote: ↑Mon May 10, 2021 9:44 pm Oh, tell me more about how you're concerned that the vaccine is more dangerous than the virus.

Lethal black fungus that rots organs emerges in Covid-19 patients across India

https://www.telegraph.co.uk/global-heal ... ts-across/

Walrus wrote: ↑Tue May 11, 2021 12:09 am India had some of the best covid numbers in the world despite its large, dense population and number of festivals. That was until the mass vaccination program began. Now they have the worst numbers.

Walrus wrote: ↑Tue May 11, 2021 12:09 am India had some of the best covid numbers in the world despite its large, dense population and number of festivals. That was until the mass vaccination program began. Now they have the worst numbers.

PhDhawk wrote: ↑Tue May 11, 2021 9:38 am

Walrus wrote: ↑Tue May 11, 2021 12:09 am India had some of the best covid numbers in the world despite its large, dense population and number of festivals. That was until the mass vaccination program began. Now they have the worst numbers.

India's vaccination rate is less than 10%...and that's AFTER all the shots they've received lately.

Their LACK of vaccines is exactly why they have this problem.

I know you want so badly for the vaccine to be a problem. But it just isn't. Facts are facts.

TraditionKU wrote: ↑Tue May 11, 2021 10:00 am i’ll add, that the lack vaccination is a two-fold problem, as India us dealing with strains that have multiple mutations

those strains very likely arose precisely because of low rates of vaccination

PhDhawk wrote: ↑Tue May 11, 2021 10:45 am

TraditionKU wrote: ↑Tue May 11, 2021 10:00 am i’ll add, that the lack vaccination is a two-fold problem, as India us dealing with strains that have multiple mutations

those strains very likely arose precisely because of low rates of vaccination

Yeah, but all the early evidence is that all the approved vaccines still offer protection against the mutant strains.

And the B.1.176 strain that is causing the most problems in India has been found in many countries, including the US, and they aren't having near the issues. The vaccines work and they appear to still work against all the more infectious mutant strains as well.

TraditionKU wrote: ↑Tue May 11, 2021 10:50 am

PhDhawk wrote: ↑Tue May 11, 2021 10:45 am

TraditionKU wrote: ↑Tue May 11, 2021 10:00 am i’ll add, that the lack vaccination is a two-fold problem, as India us dealing with strains that have multiple mutations

those strains very likely arose precisely because of low rates of vaccination

Yeah, but all the early evidence is that all the approved vaccines still offer protection against the mutant strains.

And the B.1.176 strain that is causing the most problems in India has been found in many countries, including the US, and they aren't having near the issues. The vaccines work and they appear to still work against all the more infectious mutant strains as well.

i thought i read that there is an India-specific “triple mutant”? no?

and, in some cases (don’t recall whether it’s strain or vaccine-dependent) there is reduced efficacy of the vaccines

In just a few weeks, the B.1.617 variant has become the dominant strain across India and has spread to about 40 nations, including the United Kingdom, Fiji and Singapore.

Two weeks ago, it looked as if multiple variants were behind a series of surges in India. Genomic data indicated that B.1.1.7, first identified in the United Kingdom, was dominant in Delhi and the state of Punjab, and a new variant dubbed B.1.618 was present in West Bengal. B.1.617 was dominant in Maharashtra.

But since then, B.1.617 has overtaken B.1.618 in West Bengal, has become the leading variant in many states, and is increasing rapidly in Delhi. “In some states, the surge can be tied to 617,” Sujeet Singh, director of the National Centre for Disease Control, based in New Delhi, told journalists on 5 May.

the P.1 variant, which is able to evade some immunity, contributed to a major second wave in Brazil early this year.

In a detailed genomic and structural analysis of B.1.617 published as a preprint1 on 3 May, NIV scientists identified eight mutations in the virus’s spike protein, through which it gains entry to cells. Two of them look similar to mutations that have allowed other variants of concern to become more transmissible, and a third resembles a mutation that may have allowed P.1 to partially evade immunity.

Similarly, the German team tested2 serum from 15 people who had previously been infected with SARS-CoV-2, and found that their antibodies neutralized B.1.617 about 50% less effectively than previously circulating strains. When they tested serum from participants who’d had two shots of the Pfizer vaccine, they found that the antibodies were about 67% less potent against B.1.617.

Two other small studies, one from Yadav’s team5 testing the Covaxin vaccine made by Indian firm Bharat Biotech in Hyderabad, and an as-yet-unpublished study on Covishield, showed that the vaccines continue to work. But Yadav observed small drops in the effectiveness of neutralizing antibodies generated by the Covaxin vaccine.

Scientists also warn that experiments in serum are not always a good guide to whether a variant can evade immunity from a vaccine in the real world. Vaccines can cause the production of vast quantities of antibodies, so a dip in potency might not be significant. Furthermore, other parts of the immune system, such as T cells, may not be affected.

For example, the B.1.351 variant has been linked to much steeper drops in the potency of neutralizing antibodies, but studies in humans suggest that many vaccines remain highly effective against that variant, particularly at preventing severe disease.

For these reasons, the vaccines are likely to remain effective against B.1.617 and to limit severe disease. “The vaccine is still working,” says Yadav. “If you get vaccinated, you “will be protected, and the severity will be less”.